Clinical Trial Update: The Use of Low Dose Prophylactic Naloxone Infusion to Prevent Respiratory Depression With Intrathecal Morphine. [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating low-dose prophylactic naloxone infusion to prevent respiratory depression caused by intrathecal morphine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Depression

Drugs mentioned

• Intrathecal morphine (morphine)
• Naloxone (Naloxone)

Snippet

Sponsor: University College Dublin | Conditions: Respiratory Depression | Phase 4 | Status: COMPLETED